Stay updated with breaking news from Bipolar version. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Caplyta reduced depression symptoms in patients with major depressive episodes linked to bipolar I and bipolar II disorders, according to a phase 3 randomized placebo-controlled trial in American Journal of Psychiatry. “Depressive episodes tend to last longer, are more difficult to treat and recur more often than manic or hypomanic episodes,” Suresh Durgam, MD, chief medical officer ....
Antipsychotic Effective for Bipolar Depression in Phase 3 Trial medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.